Europe Cardiovascular Needle Market Key Companies and SWOT Analysis by 2028
Europe Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Round-Bodied Needles, and Cutting Needles); Application (Open Heart Surgery, and Cardiac Valve Procedures); Usage (Single Use, and Multiple Uses); End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiovascular Centers)
- Status : Published
- Report Code : TIPRE00025899
- Category : Life Sciences
- No. of Pages : 119
- Available Report Formats :
- Last update date : November 24, 2021
2021 Market Size
US$ 24.40 Mn
Base year value
2028 Forecast
US$ 39.26 Mn
Projected by 2028
CAGR 2022-2028
7.0 %
Growth rate
Addressable Market
US$ 225.94 Mn
(2022-2028)
The cardiovascular needle market in Europe is expected to grow from US$ 24.40 Million in 2021 to US$ 39.26 Million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028.
Elderly people are at a high risk of heart diseases due to weakened immunity and other health issues. In general, aging leads to stiffening of heart muscles and blood vessels; moreover, the systolic blood pressure rises with aging. Thus, the people with the age 75 and above commonly suffer from hypertension, which may subsequently cause coronary artery disease and heart failure. According to the United Nation’s World Population Ageing 2017 report, around 962 million people were aged 60 years or above, and the number is expected to reach ~2.1 billion by 2050. The elderly population is known to have an atypical presentation of illness along with comorbidities and unfavourable outcomes. The major reason for the disease is related to age-related structural and functional changes in the cardiovascular system. Thus, the rising geriatric population, coupled with the surge in CVD prevalence among these people, is driving the cardiovascular needles market growth.
Cardiac surgery across Europe is being set back as a result of the ongoing coronavirus. Operations are being postponed, treatment delayed, and critical care staff have been redeployed to cope with the impact of the Covid-19 epidemic on health services. While evidence illustrates a significant fall in heart surgery procedures in the United States and in the UK. In England, the charity the British Heart Foundation has monitored the situation and found that around 371,000 heart operations and procedures were performed in 2020, down 22 per cent from 2019 when more than 473,000 were carried out. Operations such as coronary bypass and heart valve surgery fell from 37,000 cases to around 25,000 by the end of November 2020, compared with 2019, while procedures such as fitting stents to open blocked arteries also fell. Meanwhile, research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons showed that in the United States Covid-19 resulted in a 53% decrease nationwide in all adult cardiac surgery. Data from Public Health England show there have been at least 5,700 excess deaths from heart diseases and stroke since the pandemic began. Delays to heart operations and procedures are likely contributing to more deaths than expected.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the cardiovascular needle market. The Europe cardiovascular needle market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Cardiovascular Needle Market Segmentation
By Application
- Open Heart Surgery
- Cardiac Valve Procedures
By Usage
- Single Use
- Multiple Uses
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Cardiovascular Centres
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
Europe Cardiovascular Needle Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 24.40 Million |
| Market Size by 2028 | US$ 39.26 Million |
| CAGR (2021 - 2028) | 7.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners provided valuable market intelligence that supported our global go-to-market strategy. Their team was professional, responsive, and attentive to our feedback, providing thoughtful analysis and helpful methodological clarifications throughout the project.
Junmo Kim Chief Financial Officer (CFO), Enertech Co., Ltd.
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for